NM_018131.5:c.171C>G
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_018131.5(CEP55):c.171C>G(p.His57Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.223 in 1,607,764 control chromosomes in the GnomAD database, including 41,389 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely benign in UniProt.
Frequency
Consequence
NM_018131.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.236 AC: 35899AN: 151932Hom.: 4357 Cov.: 32
GnomAD3 exomes AF: 0.218 AC: 54051AN: 247410Hom.: 6339 AF XY: 0.225 AC XY: 30194AN XY: 133922
GnomAD4 exome AF: 0.222 AC: 322894AN: 1455714Hom.: 37026 Cov.: 31 AF XY: 0.225 AC XY: 162889AN XY: 724400
GnomAD4 genome AF: 0.236 AC: 35924AN: 152050Hom.: 4363 Cov.: 32 AF XY: 0.236 AC XY: 17518AN XY: 74318
ClinVar
Submissions by phenotype
not provided Benign:2
- -
- -
CEP55-related disorder Benign:1
This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at